
MICSI
MICSI is a YC Summer 2023 (S23) company. Based in New York, NY, USA. Team of 2.
About MICSI
Summary
MICSI builds AI software that enhances MRI and PET image quality, doubling resolution while cutting scan times in half. Imaging centers use it to process more patients per scanner without hardware upgrades, replacing manual tolerance of low signal-to-noise images and long acquisition protocols. The flagship product, MICSI-RMT, is FDA 510(k) cleared and applies an MP-PCA denoising algorithm to diffusion and functional MRI data to support more accurate quantitative analysis.
Go-to-market
Imaging centers and radiology departments are the buyers, reached through a software integration path that routes DICOM data into existing clinical workflows via a demo-request model on the company's website.
From the Y Combinator listing
Higher resolution MRI with faster scan times.
MICSI is introducing AI software that doubles resolution and halves scan time. This breakthrough enables imaging centers to significantly enhance their capacity and patient throughput, potentially saving countless lives and generating an additional $2 million of revenue per MRI scanner. Our initial offering serves as a stepping stone toward the company’s larger vision of transforming the MRI into a truly quantitative instrument that is capable of providing highly reproducible data for more accurate diagnoses and patient management.
Facts
- Healthcare / Healthcare -> Diagnostics
- New York, NY, USA
- 2
- Active
- Early
Founders (2)
- Benjamin Ades-Aron
- Gregory Lemberskiy
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works